Drawing for QYN

USPTO serial 99929330

QYN

Reviewed by CopyMark Law Group

Filing date
Status date
Registration date
—
Examiner
—
Law office
—

What this means

Status 630 means your trademark application is in the USPTO queue and has not yet been assigned to an examining attorney. This is normal shortly after filing. Examination typically begins within three to four months, though timing varies. Wait for assignment and the first examiner action. Monitor TSDR monthly for status changes to 638 (assigned) or an office action.

Status 630: Status 630 means your trademark application is in the USPTO queue and has not yet been assigned to an examining attorney. This is normal shortly after filing. Examination typically begins within three to four months, though timing varies.

Need help with QYN?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Christina M. Licursi

Christina M. Licursi Wolf, Greenfield & Sacks, P.C.600 Atlantic AvenueBoston, MA 02210-2206United States

Goods and services

ClassDescriptionStatusFirst use
005Hormone testing kits comprised of medical diagnostic reagents and assay components for measuring hormone levels for medical purposes; medical diagnostic testing kits comprised of reagents and assay components for detecting and measuring biomarkers for medical purposesACTIVE—
009Downloadable mobile application software for tracking, analyzing, and managing hormone-related health data; downloadable software for collecting, processing, and analyzing biomarker data, including patient health data; downloadable software featuring clinical decision support tools for use by clinicians, physicians, and healthcare providers in analyzing biomarker data and generating diagnostic and treatment recommendations; downloadable software for use by pharmaceutical companies in analyzing biomarker data for drug development and clinical researchACTIVE—
042Providing temporary use of non-downloadable software for analyzing hormone test data and generating reports; providing temporary use of non-downloadable software for analyzing biomarker data and generating reports; software as a service (SaaS) services featuring software for processing, aggregating, and interpreting patient biomarker data; providing temporary use of non-downloadable clinical decision support software for use by clinicians, physicians, and healthcare providers to analyze biomarker data and generate diagnostic and treatment recommendations; providing temporary use of non-downloadable software for use by pharmaceutical companies in biomarker analysis, drug development, and clinical trial optimizationACTIVE—
044Health and wellness services, namely, providing information and consulting in the field of hormonal health and balance; providing medical and health information based on analysis of biomarkers; providing clinical decision support services, namely, providing medical information and treatment recommendations based on biomarker dataACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Oct 27, 2026NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Jul 8, 2026MAFRAPPLICATION FILING RECEIPT MAILED—
Jul 8, 2026NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance